KAWARTHA LAKES-Ross Memorial Hospital has had one case of Myocarditis/Endocarditis associated with the Coronavirus vaccine to date and 42 patients have come through the emergency department as a result of adverse reactions due to the vaccine.
“As detailed by the Ontario Ministry of Health, COVID-19 vaccines, like all vaccines, may cause side effects in both adults and children, although not everyone experiences them and those who do experience them, mostly report mild side effects within the first 1-2 days after vaccination.” Ryan Young Communications Officer, Ross Memorial Hospital told Kawartha 411 News. “The most commonly reported side effects after receiving a COVID-19 vaccine are localized reactions including pain, swelling, and colour changes in the skin (e.g. red, purple) at the injection site, and tiredness, headache, muscle pain, joint pain, chills, and mild fever.”
Young says the 42 adverse reactions locally were a result of minor symptoms such as headaches, nausea, and soreness.
Ross Memorial Hospital has been administering vaccines at a drive-thru clinic located at the Lindsay Exhibition Fairgrounds since March.
“We are proud to say we are nearing 50,000 COVID-19 vaccinations administered at the site.” Young says.
There have been a total of 6,957 Adverse Events Following Immunization (AEFI)reports received in Ontario through the provincial surveillance system up to July 3,2021. The government says 6,658 AEFI reports are non-serious and 299 AEFI reports meet the serious definition.
The Haliburton Kawartha Pine Ridge District Health Unit reports 139 AEFI’s up to July 3, 2021.
Peterborough Public Health reports 146 AEFI’s. Peterborough Regional Health Centre which has a designated cardiac department would not release its numbers for heart-related adverse reactions to the Coronavirus vaccine.
As of July 3, 2021, there have been 74 reports of myocarditis or pericarditis following receipt of COVID-19 mRNA vaccines in Ontario. Of these, 22 (29.7%) were diagnosed with myocarditis and 35 (47.3%) were diagnosed with pericarditis. The remaining 17 were diagnosed with perimyocarditis , myopericarditis or inflammatory cardiac reaction of unclear significance according to Public Health. In addition, there are 29 reports classified as ‘persons under investigation’ (16 after dose one; 12 after dose two; 1 with unknown dose number) as public health units are still collecting additional information on the AEFI report.
Of the 74 reports of myocarditis or pericarditis, 43 (58.1%) individuals required hospitalization with some variation by age group according to Public Health Ontario. In the 12-17 year age group, five of the 12 reports required hospitalization (41.7%) and in the 25-29 year age group, eight of the nine reports required hospitalization (88.9%).
As of July 3, 2021, there are 29 reports of deaths temporally associated with receipt of COVID-19 vaccine that are currently classified as ‘persons under investigation’ as they do not currently meet the provincial surveillance definition. These investigations are ongoing and additional information including a cause of death (e.g., autopsy or Coroner’s report) is expected. Preliminary information suggests that these events occurred in individuals with multiple co-morbidities which may be related to the cause of death.
6 additional deaths were classified under the Serious Adverse Event Following Immunization:
- ï‚· Â Resident of a health-care institution with significant co-morbidities. The cause of death was not attributed to the vaccine.
- ï‚· Â Community dwelling senior with complex cardiovascular and renal conditions, wherein the AEFI may have contributed to but was not the underlying cause of death.
- ï‚· Â Community dwelling senior with multiple comorbidities including heart disease and an autoimmune disorder. The cause of death was not attributed to the vaccine.
- ï‚· Â An individual with VITT with death recorded in CCM (described above under Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and Thrombosis with Thrombocytopenia Syndrome (TTS)).
- ï‚· Â Individual with hypertension, wherein the cause of death was not clearly attributed to vaccine.
-   Community dwelling senior with a complex cardiovascular history. The AEFI may have contributed to but was not the underlying cause of death.
The University of Ottawa Heart Institute has admitted at least eight people with myocarditis that may be linked to the two mRNA vaccines produced by Moderna and Pfizer-BioNTech.
Read more here:https://www.cbc.ca/news/canada/ottawa/myocarditis-ottawa-mrna-vaccines-1.6088122
There were 259 reports of events managed as anaphylaxis, in which 19 met the definition of a serious AEFI in Ontario so far.
In Ontario, 19 reports of Guillian Barre Syndrome have been reported to date, 12 of those following Astra Zeneca shots. There were 259 reports of events managed as anaphylaxis, in which 19 met the definition of a serious AEFI.
Young stresses COVID-19 vaccines increase a person’s ability to fight infection if they are exposed to the virus. The vaccine activates the body’s natural immune response and makes it more ready to fight the virus.
“Receiving a COVID-19 vaccine is the best way to protect yourself and your loved ones from the virus.
15,549,309 doses of COVID-19 vaccine have been administered in Ontario to that date.
All of the stats found in this article come directly from Public Health Ontario. Here is the link:https://www.publichealthontario.ca/-/media/documents/ncov/epi/covid-19-aefi-report.pdf?sc_lang=en
